Continued Access to the Endogenex System for Participants in the ReCET Pivotal Study
Condition: Type 2 Diabetes Mellitus · Type2diabetes · Diabetes Mellitus, Type 2 · Sponsor: Endogenex, Inc.
About this study
This study is designed to collect real-world data on the safety and performance of the Endogenex System in the cohort of participants who were originally randomized to the sham control arm of the ReCET Study.
This description comes directly from the study's public registry record.
Talk to the study team
No contact information is available for this study as per the public registry record.
Always discuss trial participation with your own doctor first.
Locations (12)
| University of Alabama | Birmingham, Alabama, United States | — |
| HCA Florida Mercy Hospital | Miami, Florida, United States | — |
| Orlando Health | Orlando, Florida, United States | — |
| NorthShore University Health System | Evanston, Illinois, United States | — |
| Care Access | Quincy, Massachusetts, United States | — |
| Robert Wood Johnson Medical School | New Brunswick, New Jersey, United States | — |
| Care Access | Raleigh, North Carolina, United States | — |
| The University of Texas Health Science Center at Houston | Bellaire, Texas, United States | — |
| University of Texas Southwestern Medical School - William P. Clements Jr. University Hospital | Dallas, Texas, United States | — |
| Care Access | Houston, Texas, United States | — |
| St. Vincent's Hospital Melbourne | Fitzroy, Victoria, Australia | — |
| Baker Heart and Diabetes Institute | Melbourne, Victoria, Australia | — |
Follow this study
Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.
We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07197788